Foxa1 and Foxa2 regulate bile duct development in mice

Journal of Clinical Investigation

Volumn 119, Issue 6, 2009, Pages 1537-1545

  Li, Zhaoyu ^a   White, Peter ^a   Tuteja, Geetu ^a   Rubins, Nir ^a   Sackett, Sara ^a   Kaestner, Klaus H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE DELETION; LIVER DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BILE DUCT DISEASES; BILE DUCTS; CELL DIFFERENTIATION; CELL PROLIFERATION; FIBROSIS; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HEPATOCYTES; HYPERPLASIA; INTERLEUKIN-6; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; RECEPTORS, GLUCOCORTICOID;

EID: 67651002855     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38201     Document Type: Article

References (55)

1. Kaestner, K.H. 2005. The making of the liver: developmental competence in foregut endoderm and induction of the hepatogenic program. Cell Cycle. 4:1146-1148.
2. Friedman, J.R., and Kaestner, K.H. 2006. The Foxa family of transcription factors in development and metabolism. Cell. Mol. Life Sci. 63:2317-2328.
3. Zaret, K.S. 2002. Regulatory phases of early liver development: paradigms of organogenesis. Nat. Rev. Genet. 3:499-512.
4. Duncan, S.A. 2003. Mechanisms controlling early development of the liver. Mech. Dev. 120:19-33.
5. Lemaigre, F.P. 2003. Development of the biliary tract. Mech. Dev. 120:81-87.
6. Kaestner, K.H., et al. 1993. Six members of the mouse forkhead gene family are developmentally regulated. Proc. Natl. Acad. Sci. U. S. A. 90:7628-7631.
7. Kaestner, K.H., Hiemisch, H., Luckow, B., and Schutz, G. 1994. The HNF-3 gene family of transcription factors in mice: gene structure, cDNA sequence, and mRNA distribution. Genomics. 20:377-385.
8. Wan, H., et al. 2005. Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. J. Biol. Chem. 280:13809-13816.
9. Lee, C.S., Friedman, J.R., Fulmer, J.T., and Kaestner, K.H. 2005. The initiation of liver development is dependent on Foxa transcription factors. Nature. 435:944-947.
10. Ferri, A.L., et al. 2007. Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development. 134:2761-2769.
11. Lai, E., et al. 1991. Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. Genes Dev. 5:416-427.
12. Kaestner, K.H., Hiemisch, H., and Schutz, G. 1998. Targeted disruption of the gene encoding hepatocyte nuclear factor 3gamma results in reduced transcription of hepatocyte-specific genes. Mol. Cell. Biol. 18:4245-4251.
13. Kaestner, K.H., Katz, J., Liu, Y., Drucker, D.J., and Schutz, G. 1999. Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. Genes Dev. 13:495-504.
14. Sund, N.J., et al. 2000. Hepatocyte nuclear factor 3beta (Foxa2) is dispensable for maintaining the differentiated state of the adult hepatocyte. Mol. Cell. Biol. 20:5175-5183.
15. Besnard, V., Wert, S.E., Hull, W.M., and Whitsett, J.A. 2004. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr. Patterns. 5:193-208.
16. Zhang, L., Rubins, N.E., Ahima, R.S., Greenbaum, L.E., and Kaestner, K.H. 2005. Foxa2 integrates the transcriptional response of the hepatocyte to fasting. Cell Metab. 2:141-148.
17. Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:70-71.
18. Krupczak-Hollis, K., et al. 2004. The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis. Dev. Biol. 276:74-88.
19. Parviz, F., et al. 2003. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat. Genet. 34:292-296.
20. Loomes, K.M., et al. 2007. Bile duct proliferation in liver-specific Jag1 conditional knockout mice: effects of gene dosage. Hepatology. 45:323-330.
21. Fava, G., Glaser, S., Francis, H., and Alpini, G. 2005. The immunophysiology of biliary epithelium. Semin. Liver Dis. 25:251-264.
22. Liu, Z., et al. 1998. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology. 28:1260-1268.
23. Liu, Z., et al. 2000. Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction. Liver. 20:114-124.
24. Matsumoto, K., Fujii, H., Michalopoulos, G., Fung, J.J., and Demetris, A.J. 1994. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology. 20:376-382.
25. LeSage, G., Glaser, S., and Alpini, G. 2001. Regulation of cholangiocyte proliferation. Liver. 21:73-80.
26. Alvaro, D., Gigliozzi, A., and Attili, A.F. 2000. Regulation and deregulation of cholangiocyte proliferation. J. Hepatol. 33:333-340.
27. Strazzabosco, M., Spirli, C., and Okolicsanyi, L. 2000. Pathophysiology of the intrahepatic biliary epithelium. J. Gastroenterol. Hepatol. 15:244-253.
28. Alvaro, D., et al. 2007. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology. 132:415-431.
29. Meng, F., Yamagiwa, Y., Ueno, Y., and Patel, T. 2006. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes. J. Hepatol. 44:1055-1065.
30. Ezure, T., et al. 2000. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am. J. Pathol. 156:1627-1639.
31. Park, J., Gores, G.J., and Patel, T. 1999. Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase. Hepatology. 29:1037-1043.
32. Kamimura, D., Ishihara, K., and Hirano, T. 2003. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 149:1-38.
33. Hirano, T., Nakajima, K., and Hibi, M. 1997. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 8:241-252.
34. Park, J., Tadlock, L., Gores, G.J., and Patel, T. 1999. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology. 30:1128-1133.
35. Nozaki, I., et al. 2004. Regulation and function of trefoil factor family 3 expression in the biliary tree. Am. J. Pathol. 165:1907-1920.
36. Yokoyama, T., et al. 2006. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int. 26:467-476.
37. Chen, L.P., et al. 2009. Activation of interleukin-6/STAT3 in Rat cholangiocyte proliferation induced by lipopolysaccharide. Dig. Dis. Sci. 54:547-554.
38. Liu, Z., and Ukomadu, C. 2008. Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant. Biochem. Biophys. Res. Commun. 365:729-734.
39. Pascussi, J.M., et al. 2003. Pathophysiological factors affecting CAR gene expression. Drug Metab. Rev. 35:255-268.
40. De Bosscher, K., et al. 2000. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl. Acad. Sci. U. S. A. 97:3919-3924.
41. Bhavsar, P.K., Sukkar, M.B., Khorasani, N., Lee, K.Y., and Chung, K.F. 2008. Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-kappaB. FASEB J. 22:1807-1816.
42. Christoffels, V.M., et al. 1998. Glucocorticoid receptor, C/EBP, HNF3, and protein kinase A coordinately activate the glucocorticoid response unit of the carbamoylphosphate synthetase I gene. Mol. Cell. Biol. 18:6305-6315.
43. Sun, R., Jaruga, B., Kulkarni, S., Sun, H., and Gao, B. 2005. IL-6 modulates hepatocyte proliferation via induction of HGF/p21cip1: regulation by SOCS3. Biochem. Biophys. Res. Commun. 338:1943-1949.
44. Cressman, D.E., et al. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274:1379-1383.
45. Naugler, W.E., et al. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 317:121-124.
46. Lazaridis, K.N., Strazzabosco, M., and Larusso, N.F. 2004. The cholangiopathies: disorders of biliary epithelia. Gastroenterology. 127:1565-1577.
47. Strazzabosco, M., Fabris, L., and Spirli, C. 2005. Pathophysiology of cholangiopathies. J. Clin. Gastroenterol. 39:S90-S102.
48. Xia, J.L., Dai, C., Michalopoulos, G.K., and Liu, Y. 2006. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am. J. Pathol. 168:1500-1512.
49. Diaz, R., et al. 2008. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum. Pathol. 39:102-115.
50. Alpini, G., McGill, J.M., and Larusso, N.F. 2002. The pathobiology of biliary epithelia. Hepatology. 35:1256-1268.
51. Bochkis, I.M., et al. 2008. Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress. Nat. Med. 14:828-836.
52. Gao, N., et al. 2008. Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes Dev. 22:3435-3448.
53. Rojkind, M., and Valadez, G. 1985. Regulation of fibroblast proliferation by Kupffer cells and monocytes. Ciba Found. Symp. 114:208-221.
54. Gupta, R.K., et al. 2005. The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. J. Clin. Invest. 115:1006-1015.
55. Rubins, N.E., et al. 2005. Transcriptional networks in the liver: hepatocyte nuclear factor 6 function is largely independent of Foxa2. Mol. Cell. Biol. 25:7069-7077.